Resultados da pesquisa - Jan Budczies

Refinar resultados
  1. 1
    Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer

    Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer Por Balázs Győrffy, Paweł Surowiak, Jan Budczies, András Lánczky

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  2. 2
    Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types

    Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types Por Jan Budczies, Carsten Denkert, Balázs Győrffy, Peter Schirmacher, Albrecht Stenzinger

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  3. 3
    Optimization models for cancer classification: extracting gene interaction information from microarray expression data

    Optimization models for cancer classification: extracting gene interaction information from microarray expression data Por Alexey V. Antonov, Igor V. Tetko, Michael T. Mader, Jan Budczies, Hans‐Werner Mewes

    Publicado em 2004
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  4. 4
    Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors

    Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors Por Dan Sha, Zhaohui Jin, Jan Budczies, Klaus Kluck, Albrecht Stenzinger, Frank A. Sinicrope

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  5. 5
    Comparison of targeted next-generation sequencing and Sanger sequencing for the detection of PIK3CA mutations in breast cancer

    Comparison of targeted next-generation sequencing and Sanger sequencing for the detection of PIK3CA mutations in breast cancer Por Ruža Arsenić, Denise Treue, Annika Lehmann, Michael Hummel, Manfred Dietel, Carsten Denkert, Jan Budczies

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    Subgroup-specific immune and stromal microenvironment in medulloblastoma

    Subgroup-specific immune and stromal microenvironment in medulloblastoma Por Michael Bockmayr, Malte Mohme, Frederick Klauschen, Beate Winkler, Jan Budczies, Stefan Rutkowski, Ulrich Schüller

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    Defining molecular risk in ALK+ NSCLC

    Defining molecular risk in ALK+ NSCLC Por Petros Christopoulos, Jan Budczies, Martina Kirchner, Steffen Dietz, Holger Sültmann, Michael Thomas, Albrecht Stenzinger

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  8. 8
    What turns CREB on? And off? And why does it matter?

    What turns CREB on? And off? And why does it matter? Por André Steven, Michael Friedrich, Paul Jank, Nadine Heimer, Jan Budczies, Carsten Denkert, Barbara Seliger

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  9. 9
    The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition

    The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition Por Sherene Loi, Stefan Michiels, Sylvia Adams, Sibylle Loibl, Jan Budczies, Carsten Denkert, Roberto Salgado

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  10. 10
    Strategies for developing Ki67 as a useful biomarker in breast cancer

    Strategies for developing Ki67 as a useful biomarker in breast cancer Por Carsten Denkert, Jan Budczies, Gϋnter von Minckwitz, Stephan Wienert, Sibylle Loibl, Frederick Klauschen

    Publicado em 2015
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  11. 11
    Cancer beyond organ and tissue specificity: Next‐generation‐sequencing gene mutation data reveal complex genetic similarities across major cancers

    Cancer beyond organ and tissue specificity: Next‐generation‐sequencing gene mutation data reveal complex genetic similarities across major cancers Por Daniel Heim, Jan Budczies, Albrecht Stenzinger, Denise Treue, Peter Hufnagl, Carsten Denkert, Manfred Dietel, Frederick Klauschen

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  12. 12
    Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization

    Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization Por Jan Budczies, Frederick Klauschen, Bruno V. Sinn, Balázs Győrffy, Wolfgang Schmitt, Silvia Darb‐Esfahani, Carsten Denkert

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    Elevated HOX gene expression in acute myeloid leukemia is associated with NPM1 mutations and poor survival

    Elevated HOX gene expression in acute myeloid leukemia is associated with NPM1 mutations and poor survival Por Ádám Nagy, Ágnes Ősz, Jan Budczies, Szilvia Krizsán, Gergely Szombath, Judit Demeter, Csaba Bödör, Balázs Győrffy

    Publicado em 2019
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  14. 14
    Glutamate enrichment as new diagnostic opportunity in breast cancer

    Glutamate enrichment as new diagnostic opportunity in breast cancer Por Jan Budczies, Berit M. Pfitzner, Balázs Győrffy, Klaus‐Jürgen Winzer, Cornelia Radke, Manfred Dietel, Oliver Fiehn, Carsten Denkert

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  15. 15
    Mass Spectrometry–Based Metabolic Profiling Reveals Different Metabolite Patterns in Invasive Ovarian Carcinomas and Ovarian Borderline Tumors

    Mass Spectrometry–Based Metabolic Profiling Reveals Different Metabolite Patterns in Invasive Ovarian Carcinomas and Ovarian Borderline Tumors Por Carsten Denkert, Jan Budczies, Tobias Kind, Wilko Weichert, Peter Tablack, Jalid Sehouli, Silvia Niesporek, Dominique Könsgen, Manfred Dietel, Oliver Fiehn

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  16. 16
    Integrated analysis of the immunological and genetic status in and across cancer types: impact of mutational signatures beyond tumor mutational burden

    Integrated analysis of the immunological and genetic status in and across cancer types: impact of mutational signatures beyond tumor mutational burden Por Jan Budczies, Anja Seidel, Petros Christopoulos, Volker Endris, Matthias Kloor, Balázs Győrffy, Barbara Seliger, Peter Schirmacher, Albrecht Stenzinger, Carsten Denkert

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  17. 17
    Classical pathology and mutational load of breast cancer – integration of two worlds

    Classical pathology and mutational load of breast cancer – integration of two worlds Por Jan Budczies, Michael Bockmayr, Carsten Denkert, Frederick Klauschen, Jochen K. Lennerz, Balázs Győrffy, Manfred Dietel, Sibylle Loibl, Wilko Weichert, Albrecht Stenzinger

    Publicado em 2015
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  18. 18
    Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer - overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression

    Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer - overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disea... Por Berit Müller, Lisa Jana, Atsuko Kasajima, Annika Lehmann, Judith Prinzler, Jan Budczies, Klaus‐Jürgen Winzer, Manfred Dietel, Wilko Weichert, Carsten Denkert

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  19. 19
    Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes

    Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes Por Balázs Győrffy, Giulia Bottai, Thomas Fleischer, Gyöngyi Munkácsy, Jan Budczies, Laura Paladini, Anne‐Lise Børresen‐Dale, Vessela N. Kristensen, Libero Santarpia

    Publicado em 2015
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  20. 20
    Metabolite profiling of human colon carcinoma – deregulation of TCA cycle and amino acid turnover

    Metabolite profiling of human colon carcinoma – deregulation of TCA cycle and amino acid turnover Por Carsten Denkert, Jan Budczies, Wilko Weichert, Gert Wohlgemuth, Martin Scholz, Tobias Kind, Silvia Niesporek, Aurelia Noske, Anna Buckendahl, Manfred Dietel, Oliver Fiehn

    Publicado em 2008
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: